^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Prostate cancer: Systemic therapy for M1 CRPC…small cell/neuroendocrine prostate cancer…first-line and subsequent treatment options…chemotherapy…carboplatin/etoposide
